Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
TELA Bio Q2 2026 Earnings Call - CEO Transition and PRS Miss Prompt Guidance Withdrawal
TELA Bio reported a disappointing Q2 2026, with revenue falling 4% to $19.3 million as its Plastic and Reconstructive Surgery (PRS) segment suffered a 23% unit volume decline. The miss was driven by a...
- TELA Bio announced a leadership change, installing Heather Getz as CEO and Chairman Joseph Capper overseeing the transition, while thanking founder Antony Koblish for his early contributions.
- Second-quarter revenue came in at $19.3 million, down 4% from the prior year period, missing management's internal expectations due to weakness in the PRS portfolio.
- OviTex PRS unit volumes plummeted 23% year-over-year, dragging PRS revenue down to $5.5 million from $7.3 million in Q2 2025.
- +12 more takeaways
Bionano Genomics Q2 2026 Earnings Call - Record Consumable Sales Signal Clinical Adoption Momentum
Bionano Genomics delivered a robust second quarter in 2026, reporting $8.2 million in revenue, a 21% year-over-year increase that surpassed guidance. The growth engine is clearly visible in consumable...
- Q2 2026 revenue reached $8.2 million, up 21% year-over-year, beating the upper end of the previous guidance range of $7.5 million to $7.8 million.
- Consumable revenue surged 30% to $4.3 million, driven by a record 27% year-over-year increase in nanochannel array flow cell sales, totaling 9,219 units.
- Gross margin hit a quarterly record of 53%, up from 52% in Q2 2025, reflecting improved operational efficiency and a shift toward higher-margin recurring revenue.
- +7 more takeaways
NESR Q2 2026 Earnings Call - Record Revenue and $3 Billion Growth Acceleration
NESR delivered a stellar second quarter in 2026, reporting record revenue of $520.8 million and adjusted EBITDA of $106.2 million. The results were driven by the successful ramp-up of the massive Ghaw...
- NESR reported record second-quarter revenue of $520.8 million, a 28.7% sequential increase and 59.1% year-over-year growth, driven primarily by the ramp-up of the Ghawar contract in Saudi Arabia.
- Adjusted EBITDA reached a record $106.2 million with a margin of 20.4%, demonstrating strong operating leverage despite geopolitical headwinds.
- The company achieved its $2 billion annualized revenue run-rate target two quarters ahead of schedule, now viewing $2 billion as the floor for full-year 2026 revenue.
- +11 more takeaways
Mercer International Q2 2026 Earnings Call - Strategic Alternatives Underway as German Cost Pressures and Liquidity Constraints Mount
Mercer International’s second quarter ended in the red, with a $76 million net loss and negative EBITDA across both pulp and solid wood operations. The numbers tell a clear story of margin compression...
- Mercer reported a $76 million net loss and $1.13 per share loss in Q2 2026, driven by a $29 million non-cash inventory impairment and negative EBITDA across both pulp and solid wood segments.
- Operating liquidity contracted by $37 million to $192 million, triggering a going concern disclosure and prompting the board to actively evaluate strategic alternatives to restructure the capital base.
- German fiber costs have reached historically high levels, squeezed by Ukraine war supply constraints, record energy prices, and direct competition from wood pellet producers.
- +7 more takeaways
NETGEAR Q2 2026 Earnings Call - Enterprise Revenue Crosses Majority Threshold as Software Transformation Drives Record Margins
NETGEAR’s Q2 2026 results read like a textbook execution of a structural pivot. Enterprise revenue reached $89 million, up 7.7 percent year-over-year, and now accounts for over half of total sales and...
- Enterprise revenue reached $89 million, up 7.7 percent year-over-year, now representing over 50 percent of total company revenue.
- Enterprise non-GAAP gross margin hit a record 54.1 percent, while contribution margin expanded 660 basis points year-over-year to 25.9 percent.
- Total company revenue came in at $168.6 million, beating the high end of guidance, with non-GAAP operating income of $4 million and EPS of $0.16.
- +7 more takeaways
WillScot Mobile Mini Q2 2026 Earnings Call - Leasing Revenue Inflects to Growth Amid Raised Full-Year Guidance
WillScot Mobile Mini delivered a quarter that quietly marks a structural shift in its core business. Total revenue of $612 million beat expectations, but the real signal sits in the leasing line. Afte...
- Total revenue reached $612 million, a 4% year-over-year increase that surpassed management’s ~$585 million expectation.
- Leasing and services revenue grew 6% year-over-year, with core leasing revenue hitting a critical inflection point at approximately $450 million, up 2% year-over-year.
- Delivery and installation revenue surged 25% year-over-year, driven by a 16% jump in modular activations and a 13% rise in pending orders.
- +7 more takeaways
Clipper Realty Q2 2026 Earnings Call - Record Residential Rents Offset by Non-Cash Office Lease Termination
Clipper Realty’s second quarter underscores a classic real estate bifurcation. The residential book is performing near peak efficiency, with occupancy holding at 99 percent and new free-market leases ...
- Overall residential occupancy holds at 99 percent across stabilized assets, reflecting persistent demand in a supply-constrained New York market.
- New free-market residential leases in Q2 2026 commanded rents over 13 percent higher than prior leases, with renewals climbing 6 percent.
- The Prospect House development at 953 Dean Street fully leased its 240-unit portfolio, achieving $78 per square foot in free-market rents across a mixed-income structure.
- +7 more takeaways
MicroVision Q2 2026 Earnings Call - Margin Expansion and Multi-Vertical Traction Validate LiDAR 2.0 Pivot
MicroVision’s second quarter reads like a deliberate course correction. Revenue climbed to $1.5 million, gross margin hit 44 percent, and management lifted full-year margin guidance to 40 to 45 percen...
- Q2 revenue reached $1.5 million, up $1.3 million year-over-year, with H1 revenue hitting $2.4 million driven by IRIS sensor shipments and semiconductor services.
- Gross margin expanded to 44 percent in Q2, prompting management to raise full-year guidance to 40 to 45 percent on favorable product mix and supply chain efficiencies.
- The LiDAR 2.0 strategy is moving from concept to cash flow, with active commercial traction across industrial, defense, robotics, and newly targeted aerial markets.
- +7 more takeaways
MP Materials Q2 2026 Earnings Call - Heavy Rare Earth Expansion and Q4 Commercial Magnet Ramp Drive Record Revenue
MP Materials reported a quarter where execution outpaced the usual scaling friction. NdPr sales jumped 127 percent year over year to over 1,000 metric tons. Consolidated adjusted EBITDA more than doub...
- NdPr production reached 840 metric tons in Q2, up 41 percent year over year, while sales exceeded 1,000 metric tons for the second straight quarter, surging 127 percent.
- Consolidated adjusted EBITDA climbed to $28.5 million, a $41 million improvement, driven by volume growth and pricing dynamics that pushed adjusted diluted EPS to a loss of just $0.01.
- Commercial magnet shipments to General Motors are on track for Q4 2026, following successful in-vehicle qualification testing and a precursor production run that delivered over 40 percent adjusted EBITDA margins.
- +7 more takeaways
Natera Q2 2026 Earnings Call - Record MRD Volumes and First FDA Companion Diagnostic Approval Drive Raised Guidance
Natera just cleared a $753 million revenue hurdle, pushing full-year guidance up by $100 million at the midpoint. The numbers tell a straightforward story of execution. One point zero four million tes...
- Revenue surged 38 percent year over year to $753 million, prompting a $100 million midpoint increase in full-year guidance to $2.85 billion to $2.91 billion.
- Clinical MRD volumes hit a record 283,000 units, up 56 percent year over year, with a sequential jump of 34,000 units driven by commercial hiring, regulatory approvals, and guideline updates.
- Signatera ASPs rose to roughly $1,275, supported by Medicare Advantage and commercial payer wins, with management reaffirming a long-term target near $2,000.
- +9 more takeaways